Navigation Links
Targeting sugar on blood vessels may inhibit cancer growth

uced by Genentech, has been shown to block a major pro-angiogenesis molecule called vascular endothelial growth factor (VEGF), thus inhibiting the growth of vasculature. The drug has been used along with chemotherapy in humans to successfully inhibit the growth of tumors in colon and lung cancers.

"If novel drugs can be developed to target tumor heparan sulfate, we might be able to make a leap in cancer-fighting therapies, because several molecules critical to tumor endothelial growth also bind to heparan sulfate," Fuster said. "Altering this binding would allow for suppression of a broader array of the tumor ‘fuels?for angiogenesis, without a major effect on normal vascular function."

The researchers hope to develop novel therapies by inhibiting endothelial heparan sulfate in the tumor environment. An example would be developing small-molecule inhibitors of Ndst1. By affecting a broad array of molecules ?such as VEGF, fibroblast growth factor, platelet-derived growth factor, or others that impact angiogenesis in a variety of carcinomas ?this therapy could be used to inhibit cancer growth and metastasis with fewer side effects.
'"/>

Source:University of California - San Diego


Page: 1 2

Related biology news :

1. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
2. Best of both worlds -- Targeting a single gene could inhibit bone decay and stimulate bone growth
3. Targeting tumors the natural way
4. Thai spice helps cut blood sugar swings
5. Cats indifference towards sugar explained
6. Life-extending protein keeps blood sugar in check
7. Too much sugar not good for coral reefs
8. Darkness unveils vital metabolic fuel switch between sugar and fat
9. Scientists seek to unwrap the sweet mystery of the sugar coat on bacteria
10. A single sugar found responsible for an antibodys ability to treat inflammation
11. Researchers attack tumor cells by exploiting dependency on sugar metabolism
Post Your Comments:
(Date:12/14/2009)... -- Researchers at Rice University and Baylor College of ... be tracked in real time with MRI as it ... fluorescent dye and kills them with heat. The all-in-one ... growing field called "theranostics" that develops technologies physicians can ... procedure. , The research is available online in the ...
(Date:12/14/2009)... Infectious diseases can be transmitted by sneezing, touching, or ... the face, a habit that may have driven the ... parasite. , Jacqueline Upcroft, a member of f1000 Biology, ... colleagues published in PLoS One. This led them to ... the diseased jaw bones seen in many tyrannosaurid fossils. ...
(Date:12/14/2009)... HAMILTON, ON, December 10, 2009If you are spending the ... and wondering whether you would be better off with ... fish. , A research team from McMaster University ... that among cichlids, a species that lives in groups, ... , The results appear in the current issue of ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2North Highland Opens First Asia Office in Shanghai 52919 1North Highland Opens First Asia Office in Shanghai 52919 2Resvera Health Rx Launches All Natural Resveratrol Based Supplement with Anti Aging and Disease Fighting Properties 52917 1Resvera Health Rx Launches All Natural Resveratrol Based Supplement with Anti Aging and Disease Fighting Properties 52917 2Resvera Health Rx Launches All Natural Resveratrol Based Supplement with Anti Aging and Disease Fighting Properties 52917 3RadMD First to Offer CME Certified Education and Training For Medical Imaging in Clinical Trials 13230 1RadMD First to Offer CME Certified Education and Training For Medical Imaging in Clinical Trials 13230 2
... expressions of emotion are hardwired into our genes, according ... of Personality and Social Psychology . The research suggests ... a product of cultural learning. The study is the ... blind individuals use the same facial expressions, producing the ...
... 9 First Coast Service Options (FCSO) has ... Medicare reimbursement solutions, to support a new Medicare ... & Medicaid Services (CMS).Under this new contract, FCSO ... between health care providers and organizations offering Medicare ...
... at the University of Warwick has discovered the trigger that ... stage of embryo development. Their discovery could also provide new ... and are bound together at key parts of analogous cell ... binding togetgher of too many of too few of a ...
Other Biology News:Facial expressions of emotion are innate, not learned, says new study 2FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract 2How chromosomes meet in the dark -- Switch that turns on X chromosome matchmaking 2How chromosomes meet in the dark -- Switch that turns on X chromosome matchmaking 3
(Date:12/15/2009)... Corporation (Nasdaq: RGEN ) today announced that ... to support the ongoing development of new treatments ... (MDA). This grant will support the completion ... of a drug candidate for human clinical trials. ... important funding for Repligen,s research but it also ...
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... - Market Forecasts to 2015, Pipeline Analysis ... http://www.reportlinker.com/p0168104/The-Future-of-Orphan-Diseases-Therapeutics---Market-Forecasts-to-2015-Pipeline-Analysis-and-Reimbursement.html ,, Summary ... latest research "The Future of Orphan Diseases ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
(Date:12/15/2009)... Mosaic Company (NYSE: MOS ) plans to ... and financial tables on Tuesday, January 5, 2010, after ... Exchange. Results will be available on Mosaic,s website ... a conference call with presentation slides on Wednesday, January ... will begin at 11:00 a.m. Eastern Standard Time (10:00 ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... Calif., March 10 Beckman Coulter,Inc. (NYSE: ... of,products that simplify, automate, and innovate complex biomedical ... Vice President of,Strategy and Business Development, will present ... Thursday, March 13, 2008, at 4:00 a.m.,(ET)., ...
... 10 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ) (TSX: ... and quarter ended December 31, 2007. All results are ... loss for the year ended December 31, 2007, was ... with $36.4 million, or $2.38,per basic and diluted share ...
... News and, add to it in-Depth Analysis and Commentary That ... ... March 10 Elsevier, the world,s,leading publisher of science, technical ... Inc., a healthcare,business intelligence company that provides analysis and commentary ...
Other Biology Technology:Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference 2Oncothyreon reports full year and fourth quarter 2007 financial results 2Oncothyreon reports full year and fourth quarter 2007 financial results 3Oncothyreon reports full year and fourth quarter 2007 financial results 4Oncothyreon reports full year and fourth quarter 2007 financial results 5Oncothyreon reports full year and fourth quarter 2007 financial results 6Oncothyreon reports full year and fourth quarter 2007 financial results 7Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 2Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company 3
... Series Systems provide fast and reliable ... proteomics and drug development laboratories. Staccato ... customer specifications, providing solutions that are ... Staccato Custom Systems are controlled with ...
... Use in any standard fixed-angle ... 16,000 g.,Spin- centrifuge tube filters ... within a centrifuge tube. They filter ... removal, HPLC sample preparation, removal of ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: polystyrene ...
... optically clear polystyrene formulation , High antibody-binding ... , Plates are certified for performance ... , Eight-well strips fit snugly in ... in use even if turned upside down ...
Biology Products: